Antibodies are an indispensable tool for the diagnosis, and treatment of several diseases. High affinity and extraordinary specificity for their target antigens are some properties desirable ...

Despite the absence of a light chain, VHHs are capable of producing functional antibodies. More specifically, the single N-terminal domain of camelid antibodies is fully capable of antigen binding, ...

The use of Camelid antibodies has important implications for future development of reagents for diagnosis and therapeutics in diseases involving a group of enzymes called serine proteases, report ...

Single-domain antibodies, or nanobodies, have recently been thrust into the spotlight as a potential treatment for COVID-19. In fact, a COVID-19 nanobody-based treatment developed by the Beroni Group, ...

The camelid nanobody (center), first identified in camels, is a heavy-chain antibody that is much smaller and easier to program than antibodies found in most organisms, including humans, like that at ...

The use of Camelid antibodies has important implications for future development of reagents for diagnosis and therapeutics in diseases involving a group of enzymes called serine proteases. Antibodies ...